| Formulary Chapter 13: Skin - Full Chapter
|
| Notes: |
Dermatology services are provided by visiting consultants from Salford Royal Foundation Trust, and choice of therapy is therefore guided by SRFT's formulary. To confirm the formulary status of a product, please see http://www.srft.nhs.uk/for-professionals/formulary/ |
|
| Details... |
| 13.01 |
Management of skin conditions |
|
|
|
|
| 13.01.02 |
Suitable quantities for prescribing |
|
|
| 13.01.03 |
Excipients and sensitisation |
|
|
| 13.02 |
Emollient and barrier preparations |
|
|
 |
|
If the patient’s symptoms have not improved after using these preferred treatments then please refer to the BNF for other options. This is in preference to referring to a specialist centre.
Patients who have been discharged or recommended a product from a specialist centre should be maintained on the same product when it is effective.
Those people without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter. | |
|
|
|
QV®
|
 Restricted
|
Skin lotion
Cream
Intensive ointment
Only on advice of tissue viability
|
|
|
Aveeno®
|
Restricted
|
Cream
Dermatology only
|
|
|
Cetraben®
|
Formulary
|
Cream
|
|
|
Diprobase®
|
Formulary
|
Cream
Ointment
|
|
|
DoubleBase®
|
Formulary
|
Gel
|
|
|
E45® Cream
|
Formulary
|
Cream
|
|
|
Emulsifying Ointment BP
|
Formulary
|
Ointment
|
 MHRA (2008): Paraffin-based treatments: risk of fire
|
Epaderm®
|
Formulary
|
Cream
Ointment
|
|
|
Hydromol® ointment
|
Formulary
|
Ointment
|
|
|
Lipobase®
|
Restricted
|
Cream
Dermatology only
|
|
|
Liquid and White Soft Paraffin Ointment (50:50)
|
Formulary
|
Ointment
|
|
|
Oilatum®
|
Formulary
|
Cream
|
|
|
Unguentum M®
|
Restricted
|
Cream
Dermatology only
|
|
|
White Soft Paraffin BP
|
Formulary
|
Ointment
|
MHRA (2008): Paraffin-based treatments: risk of fire
|
Yellow Soft Parrafin BP
|
Formulary
|
Jelly
|
MHRA (2008): Paraffin-based treatments: risk of fire
|
Zerobase®
|
Formulary
|
Cream
|
|
|
|
|
| 13.02.01 |
Preparations containing urea |
|
|
| |
Preparations containing urea should only be used for severely dry, scaling skin. |
|
Balneum® Plus cream
|
Formulary
|
Cream
|
|
|
Calmurid®
(Urea 10%, lactic acid 5%)
|
Formulary
|
Cream
|
|
|
| 13.02.01 |
With antimicrobials |
|
|
Dermol®
|
Formulary
|
Cream
Dermol 500 Lotion
|
 MHRA (2012): All products containing chlorhexidine
|
| 13.02.01.01 |
Emollient bath and shower preparations |
|
|
Aqueous Cream BP
|
Formulary
|
|
|
|
Balneum Plus Bath Oil
|
Formulary
|
|
|
|
Hydromol® bath and shower emollient
|
Formulary
|
|
|
|
Oilatum® Bath Additive
|
Formulary
|
|
|
|
QV®
|
Restricted
|
Bath oil
Gentle wash
Only on advice of tissue viability
|
|
|
| 13.02.01.01 |
With antimicrobials |
|
|
Dermol® 600 bath emollient
|
Formulary
|
|
MHRA (2012): All products containing chlorhexidine
|
Emulsiderm® Liquid Emulsion
|
Formulary
|
|
|
|
Oilatum®Plus Bath Additive
|
Formulary
|
|
|
|
| 13.02.02 |
Barrier preparations |
|
|
Conotrane®
|
Formulary
|
Cream
|
|
|
Drapolene®
|
Formulary
|
Cream
|
|
|
Metanium®
|
Formulary
|
Ointment
|
|
|
Siopel®
|
Formulary
|
Cream
|
|
|
Sprilon®
|
Formulary
|
Spray
|
|
|
Sudocrem®
|
Formulary
|
Cream
|
|
|
Cavilon®Film
|
Formulary
|
Barrier Preparation
 Obtained through SUPPLIES not pharmacy
|
|
|
| 13.03 |
Topical local anaesthetics and antipruritics |
|
|
Calamine
|
Formulary
|
Cream
Lotion
|
|
|
Crotamiton (Eurax®)
|
Formulary
|
Cream
Lotion
|
|
|
Levomenthol (Dermacool®)
(Menthol in Aqueous Cream)
|
Formulary
|
Cream
|
|
|
| 13.04 |
Topical corticosteroids |
|
|
Betamethasone (as Dipropionate) 0.05% with Salicylic Acid 3% (Diprosalic®)
(Potency: Potent)
|
Formulary
|
Ointment
Scalp Application
|
|
|
Betamethasone (as Valerate) 0.025% (Betnovate-RD®)
(Potency: Moderate)
|
Formulary
|
Cream
Ointment
|
|
|
Betamethasone (as Valerate) 0.1% (Betnovate Scalp®)
(Potency: Potent)
|
Formulary
|
Scalp application
|
|
|
Betamethasone (as Valerate) 0.1% (Non-proprietary or Betnovate®)
(Potency: Potent)
|
Formulary
|
Cream
Ointment
|
|
|
Betamethasone Valerate 0.1% Scalp Application (Betacap®)
(Potency: Potent)
|
Formulary
|
Scalp application
|
|
|
Clobetasol Propionate 0.05% (Dermovate®)
(Potency: Very Potent)
|
Formulary
|
Cream
Ointment
Scalp Application
|
|
|
Clobetasol Propionate 0.05% (Etrivex®)
(Potency: Very Potent)
|
Restricted
|
Shampoo
Dermatology only
|
|
|
Clobetasone Butyrate 0.05% (Eumovate®)
(Potency: Moderate)
|
Formulary
|
Cream
Ointment
|
|
|
Fludroxycortide (Haelan®)
(Potency: Moderate)
|
Formulary
|
Cream
Ointment
Tape (for chronic localised recalcitrant dermatoses, but not acute or weeping)
|
|
|
Fluocinolone Acetonide 0.0025% (Synalar 1 in 10 Dilution®)
(Potency: Mild)
|
Formulary
|
Cream
|
|
|
Fluocinolone Acetonide 0.00625% (Synalar 1 in 4 Dilution®)
(Potency: Moderate)
|
Formulary
|
Cream
Ointment
|
|
|
Fluocinolone Acetonide 0.025% (Synalar®)
(Potency: Potent)
|
Formulary
|
Cream
Gel
Ointment
|
|
|
Fluocinonide 0.05% (Metosyn®)
|
Restricted
|
FAPG cream
Dermatology only
|
|
|
Hydrocortisone
(Potency: Mild)
|
Formulary
|
Cream (0.5%, 1%, 2.5%)
Ointment (0.5%, 1%, 2.5%)
|
|
|
Hydrocortisone 1%, Urea 10% and Lactic Acid 5% (Calmurid HC®)
(Potency: Moderate)
|
Formulary
|
Cream
|
|
|
Hydrocortisone Butyrate 0.1% (Locoid®)
(Potency: Potent)
|
Formulary
|
Cream
Ointment
|
|
|
Mometasone Furoate 0.1% (Non-proprietary or Elocon®)
(Potency: Potent)
|
Restricted
|
Cream
Ointment
Dermatology only
|
|
|
|
|
|
|
| 13.04 |
With antimicrobials |
|
|
Betamethasone (as Valerate) 0.1% with Clioquinol (Non proprietary or Betnovate-C®)
(Potency: Potent)
|
Formulary
|
Cream
Ointment
|
|
|
Betamethasone (as Valerate) 0.1% with Fucidic Acid 2% (Fucibet®)
(Potency: Potent)
|
Formulary
|
Cream
|
|
|
Betamethasone (as Valerate) 0.1% with Neomycin Sulphate 0.5% (Non-proprietary or Betnovate-N®)
(Potency: Potent)
|
Formulary
|
Cream
Ointment
|
|
|
Betamethasone Dipropionate 0.064% with Clotrimazole 1% (Lotriderm®)
(Potency: Potent)
|
Formulary
|
Cream
|
|
|
Clobetasone butyrate 0.05% with Oxytetracycline and Nystatin (Trimovate®)
(Potency: Moderate)
|
Formulary
|
Cream
|
|
|
Fluocinolone Acetonide 0.025% with Clioquinol 3% (Synalar C®)
(Potency: Potent)
|
Formulary
|
Cream
Ointment
|
|
|
Fluocinolone Acetonide 0.025% with Neomycin Sulphate 0.5% (Synalar N®)
(Potency: Potent)
|
Formulary
|
Cream
Ointment
|
|
|
Hydrocortisone 0.5% with Nystatin and Chlorhexidine (Nystaform-HC®)
(Potency: Mild)
|
Formulary
|
Cream
Ointment
|
|
|
Hydrocortisone 0.5% with Nystatin, Benzalkonium and Dimeticone (Timodine®)
(Potency: Mild)
|
Formulary
|
Cream
|
|
|
Hydrocortisone 1% with Clotrimazole 1% (Canesten HC®)
(Potency: Mild)
|
Formulary
|
Cream
|
|
|
Hydrocortisone 1% with Miconazole Nitrate 2% (Daktacort®)
(Potency: Mild)
|
Formulary
|
Cream
Ointment
|
MHRA Safety Alert: serious interactions between topical miconazole and warfarin
|
Hydrocortisone Acetate 1% with Fusidic Acid 2% (Fucidin H®)
(Potency: Mild)
|
Formulary
|
Cream
|
|
|
Triamcinolone Acetonide 0.1% with Chlortetracycline Hydrochloride 3% (Aureocort®)
(Potency: Potent)
|
Formulary
|
Ointment
|
|
|
| 13.05 |
Preparations for eczema and psoriasis |
|
|
|
|
| 13.05.01 |
Preparations for eczema |
|
|
Alitretinoin (Toctino®)
|
Restricted
|
Capsules
Dermatology (Salford Royal) only
|
MHRA(2013): Oral retinoids: pregnancy prevention
NICE TA177: Eczema (chronic) - alitretinoin
|
|
|
| 13.05.02 |
Preparations for psoriasis |
|
|
Dimethyl fumarate (Skilarence®)
|
Restricted
|
Tablets
Dermatology only
|
GMMMG: Biologics Pathway for Psoriasis
NICE TA475: Dimethyl fumarate for treating moderate to severe plaque psoriasis
|
Methoxypsoralen
|
Restricted
|
Tablets
Dermatology only
|
|
|
| 13.05.02 |
Topical preparations for psoriasis |
|
|
Calcipotriol
(Non-proprietary or Dovonex®)
|
Restricted
|
Ointment
Scalp solution
To be commenced on advice of dermatology only
|
NICE CG153: Psoriasis
|
Calcipotriol 50micrograms/g with Betamethasone 0.05% (Dovobet®)
|
Restricted
|
Ointment
Gel
To be commenced on advice of dermatology only
|
|
|
Calcitriol 3micrograms/g (Silkis®)
|
Restricted
|
Ointment
To be commenced on advice of dermatology only
|
|
|
Coal Tar 1% Lotion
|
Formulary
|
Lotion
|
|
|
Coal Tar and Salicylic Acid in Unguentum M
|
Restricted
|
To be commenced on advice of dermatology only
|
|
|
Coal Tar in Salicylic Acid Ointment
|
Formulary
|
Ointment
|
|
|
Coal Tar in Yellow Soft Paraffin
|
Formulary
|
0.5%
1%
3%
5%
10%
15%
20%
25%
|
|
|
Coal Tar Paste
|
Formulary
|
Paste
|
|
|
Dithranol (Dithrocream®)
|
Formulary
|
Cream: 0.1%, 0.25%, 0.5%, 1%, 2%.
|
|
|
Dithranol in Zinc and Salicylic Acid (in Lassar's Paste)
(aka Dithranol Paste BP)
|
Formulary
|
Paste
 unlicensed
|
|
|
Psoriderm® (Coal tar 6%)
|
Formulary
|
Cream
|
|
|
Sebco®
|
Formulary
|
Scalp Ointment
|
|
|
Tacalcitol (Curatoderm®)
|
Restricted
|
Lotion
Ointment
To be commenced on advice of dermatology only
|
|
|
Zinc and Salicylic Acid Paste BP (Lassar's Paste)
|
Formulary
|
Paste
unlicensed
|
|
|
Calamine and Coal Tar Ointment
|
Formulary
|
Ointment
|
|
|
| 13.05.02 |
Oral retinoids for psoriasis |
|
|
Acitretin (Neotigason®)
|
Formulary
|
Capsules
Dermatology only
|
MHRA (2013): Oral retinoids: pregnancy prevention
UKMI Q&A: Can acitretin be given to patients with renal impairment or patients on renal replacement therapies?
|
| 13.05.03 |
Drugs affecting the immune response |
|
|
Adalimumab (Humira®)
|
Formulary
|
|
NICE (2008) Adalimumab for the treatment of adults with psoriasis. (TA146).
|
Azathioprine
|
Formulary
|
Tablets
unlicensed indication (severe refractory eczema)
|
 UKMI Q&A: Can mothers breastfeed while taking azathioprine?
|
Ciclosporin
|
Formulary
|
Capsules
Oral Solution
Must be prescribed by BRAND. (See Section 8.2.2.)
|
|
|
Etanercept (Enbrel®)
|
Formulary
|
|
NICE TA103: Psoriasis - efalizumab and etanercept
|
Infliximab (Remicade®)
|
Formulary
|
|
NICE TA134: Infliximab for psoriasis
|
Methotrexate
|
Formulary
|
Tablets
Injection
|
NPSA Alert (2006): Improving compliance with oral methotrexate
|
Mycophenolate mofetil
|
Formulary
|
Tablets
Capsules
Oral suspension
unlicensed indication (severe refractory eczema)
|
MHRA (2015): Mycophenolate mofetil: risk of hypogammaglobulinaemia and risk of bronchiectasis
MHRA Safety Alert: Contraception advice for male patients
MHRA Safety Alert: Pregnancy prevention advice
|
Pimecrolimus 1% Cream (Elidel®)
|
Formulary
|
Cream
Consultant Dermatologist only, in line with NICE Guidance
|
NICE TA82: Pimecrolimus and tacrolimus for atopic dermatitis (eczema)
|
Secukinumab (Cosentyx®)
|
Formulary
|
|
GMMMG Harmonised Biologics Pathway for Ankylosing Spondylitis
NICE TA407: Secukinumab for active ankylosing spondylitis
|
Tacrolimus (Protopic®)
|
Formulary
|
0.03% Ointment
0.1% Ointment
Consultant Dermatologist only
|
MHRA (2012): Tacrolimus ointment: possible risk of malignancies
NICE TA82: Pimecrolimus and tacrolimus for atopic dermatitis (eczema)
|
Ustekinumab
|
Formulary
|
NICE and GMMMG recommend ustekinumab as an option, alone or in combination with methotrexate, for treating active psoriatic arthritis in adults only when:
• treatment with TNF alpha inhibitors is contraindicated but would otherwise be considered
• or the person has had treatment with 1 or more TNF–alpha inhibitors.
Consideration should be given to discontinuing treatment in patients who have shown no response up to 28 weeks of treatment.
Available via Patient Access Scheme: please contact pharmacy for details
|
MHRA 2015: Ustekinumab: risk of exfoliative dermatitis
NICE (2015) Ustekinumab for treating active psoriatic arthritis (TA340)
NICE TA180: Psoriasis - ustekinumab
|
|
|
|
|
|
|
|
|
| 13.06.01 |
Topical preparations for acne |
|
|
|
|
| 13.06.01 |
Benzoyl peroxide |
|
|
Benzoyl Peroxide 2.5 - 10%
(Various Brands)
|
Formulary
|
Gel
Lotion
|
|
|
Benzoyl Peroxide with antimicrobials (Quinoderm®)
|
Formulary
|
Cream
|
|
|
| 13.06.01 |
Topical antibacterials for acne |
|
|
| |
Use non-antibiotic antimicrobials (such as benzoyl peroxide or azelaic acid) to avoid development of resistance to erythromycin or clindamycin. |
|
Clindamycin 1% (Dalacin T®)
|
Formulary
|
Topical solution
|
|
|
Clindamycin 1% (Zindaclin®)
|
Formulary
|
Gel
|
|
|
Erythromycin 2% (Stiemycin®)
|
Formulary
|
Topical solution
|
|
|
Erythromycin 40mg with Zinc Acetate 12mg/mL (Zineryt®)
|
Formulary
|
Topical solution
|
|
|
| 13.06.01 |
Topical retinoids and related preparations for acne |
|
|
| |
Topical retinoids are contraindicated in pregnancy |
|
| 13.06.01 |
Other topical preparations for acne |
|
|
| 13.06.02 |
Oral preparations for acne |
|
|
| 13.06.02 |
Oral antibiotics for acne and rosacea |
|
|
|
Erythromycin
|
First Choice
|
Tablets
First choice for rosacea. Alternative to oxytetracycline for acne.
|
|
|
Oxytetracycline
|
First Choice
|
Tablets
First choice for acne and rosacea
|
|
|
Doxycycline
|
Formulary
|
Capsules
Alternative choice for acne and rosacea
|
|
|
Lymecycline
|
Formulary
|
Capsules
To be initiated by Dermatology only
Alternative choice for acne only
|
|
|
| 13.06.02 |
Hormone treatment for acne |
|
|
Co-Cyprindiol 2000/35
(Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms) (Dianette®)
|
Formulary
|
Tablets
|
|
|
| 13.06.02 |
Oral retinoid for acne |
|
|
| |
Retinoids are contraindicated in pregnancy |
|
Isotretinoin (Roaccutane®)
|
Formulary
|
Capsules
Dermatology only
|
MHRA (2007): Isotretinoin for severe acne: who should prescribe it
MHRA (2010): Isotretinoin: risk of serious skin reactions
MHRA (2013): Oral retinoids: pregnancy prevention
MHRA (2014): Isotretinoin: reminder of possible risk of psychiatric disorders
MHRA (2017): Rare reports of erectile dysfunction and decreased libido
|
| 13.07 |
Preparations for warts and calluses |
|
|
Salicylic Acid 16.7% with Lactic Acid 16.7% (Salactol®or Duofilm®)
|
First Choice
|
Paint
|
|
|
Silver Nitrate 95% with Potassium Nitrate 5% (AVOCA®)
|
Formulary
|
Caustic Applicator (stick)
|
|
|
Trichloroacetic Acid
|
Formulary
|
Solution
|
|
|
|
|
Imiquimod (Aldara®)
|
Formulary
|
5% Cream
|
|
|
Podophyllotoxin (Condyline®or Warticon®)
|
Formulary
|
|
|
|
| 13.08 |
Sunscreens and camouflagers |
|
|
| 13.08.01 |
Sunscreen preparations |
|
|
| |
Sunscreens are only prescribable for ACBS approved conditions, i.e. abnormal cutaneous photosensitivity resulting from genetic disorders or photodermatoses including vitiligo and those resulting from chemotherapy. |
|
Aminolevulinic acid (Metvix)
|
Restricted
|
Cream
Dermatology Only
|
|
|
Anthelios® Melt In Cream SPF50
|
Restricted
|
Cream
Dermatology Only
|
|
|
E45 Sun Reflective Sunscreen®
|
Formulary
|
Preparations with an SPF less than 30 should not be prescribed.
|
|
|
Sunsense® Ultra SPF 50+
|
Formulary
|
Lotion
Preparations with an SPF less than 30 should not be prescribed.
|
|
|
Uvistat®
|
Formulary
|
Cream
Ultrablock Cream
Preparations with an SPF less than 30 should not be prescribed.
|
|
|
Dundee reflective sun creams (Dundee Block®)
|
Restricted
|
Dermatology Only
unlicensed
|
|
|
| 13.08.01 |
Photodamage |
|
|
Fluorouracil 0.5%, Salicylic Acid 10% (Actikerall®)
|
Restricted
|
Solution
Dermatology only
|
|
|
Ingenol mebutate (Picato®)
|
Restricted
|
Gel
Dermatology Only
|
|
|
Methyl-5-Aminolevulinate (Metvix®)
|
Restricted
|
Cream
Dermatology Only
|
|
|
|
|
| 13.09 |
Shampoos and other preparations for scalp and hair conditions |
|
|
Alphosyl 2 in 1® (Coal Tar Extract 5% (Alcoholic))
|
Formulary
|
Shampoo
|
|
|
Capasal® Shampoo
|
Formulary
|
Shampoo
|
|
|
Ceanel Concentrate® Shampoo
|
Formulary
|
Shampoo
|
|
|
Ketoconazole 2% Shampoo
|
Formulary
|
Shampoo
|
|
|
Polytar AF®
|
Formulary
|
Shampoo
|
|
|
Polytar®
|
Formulary
|
Liquid
|
|
|
Selenium Sulphide 2.5% Shampoo (Selsun®)
|
Formulary
|
Shampoo
|
|
|
T/Gel® Therapeutic Shampoo (Coal tar extract 2%)
|
Formulary
|
Shampoo
|
|
|
|
|
Co-Cyprindiol 2000/35
(Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms) (Dianette®)
|
First Choice
|
Tablets
|
MHRA 2013: Co-cyprindiol: balance of benefits and risks remains positive
|
Eflornithine 11.5% Cream (Vaniqa®)
|
Restricted
|
Dermatology only
|
GMMMG NTS Recommendation: Eflornithine Cream
|
| 13.09 |
Androgenetic alopecia |
|
|
| 13.10 |
Anti-infective skin preparations |
|
|
| 13.10.01 |
Antibacterial preparations |
|
|
| 13.10.01.01 |
Antibacterial preparations only used topically |
|
|
Mupirocin (Bactroban®)
|
Formulary
|
See 12.02.03
|
|
|
Polyfax® Ointment
|
Formulary
|
Ointment
|
|
|
Silver Sulfadiazine 1% Cream (Flamazine®)
|
Formulary
|
Cream
|
|
|
| 13.10.01.02 |
Antibacterial preparations also used systemically |
|
|
Fusidic Acid 2% (Fucidin®)
|
Formulary
|
Cream
Ointment
|
|
|
Metronidazole gel
(0.75% or 0.8%)
|
Formulary
|
Gel
|
|
|
| 13.10.02 |
Antifungal preparations |
|
|
Amorolfine (Loceryl®)
|
Restricted
|
Dermatology Only
|
|
|
Clotrimazole 1%
|
Formulary
|
Cream
Solution
Spray
|
|
|
Ketoconazole 2% Cream (Nizoral®)
|
Formulary
|
Cream
|
|
|
Miconazole 2% Cream
|
Formulary
|
Cream
|
MHRA Safety Alert: serious interactions with warfarin
|
Nystatin Cream
|
Formulary
|
Cream
|
|
|
Nystatin with Chlorhexidine cream (Nystaform®)
|
Formulary
|
Cream
|
|
|
Salicylic Acid Ointment
|
Formulary
|
Ointment
|
|
|
Terbinafine 1% cream
|
Formulary
|
Cream
|
|
|
| 13.10.03 |
Antiviral preparations |
|
|
Aciclovir (Zovirax®)
|
Formulary
|
Cream
|
|
|
| 13.10.04 |
Parasiticidal preparations |
|
|
| 13.10.04 |
Scabies and Crab Lice |
|
|
Permethrin 5% (Lyclear® Dermal Cream)
|
Formulary
|
Cream
|
|
|
Malathion 0.5% (Derbac-M®)
|
Formulary
|
Liquid
|
|
|
Ivermectin
|
Formulary
|
Tablets
unlicensed
|
|
|
Permethrin 1% (Lyclear® Creme Rinse)
|
Formulary
|
INSUFFICIENT CONTACT TIME, THEREFORE NOT RECOMMENDED
|
|
|
|
|
|
|
|
|
|
|
Dimeticone (Hedrin®)
|
Formulary
|
Lotion
|
|
|
Malathion 0.5% (Derbac-M®)
|
Formulary
|
Liquid
|
|
|
|
|
| 13.10.05 |
Preparations for minor cuts and abrasions |
|
|
Cetrimide 0.5% Cream
|
Formulary
|
Cream
|
|
|
Proflavine Cream, BPC
|
Formulary
|
Cream
|
|
|
Magnesium Sulphate Paste BP
|
Formulary
|
Paste
|
|
|
| 13.10.05 |
Collodion |
|
|
| 13.10.05 |
Skin tissue adhesive |
|
|
| |
Obtained through NHS Supplies |
|
| 13.11 |
Skin cleansers, antiseptics, and desloughing agents |
|
|
| 13.11.01 |
Alcohols and saline |
|
|
Industrial Methylated Spirit BP
|
Formulary
|
|
|
|
Sodium Chloride 0.9%
|
Formulary
|
Solution
|
|
|
| 13.11.02 |
Chlorhexidine salts |
|
|
| |
Order through NHS Supplies. (Other brands may be available). |
|
Hibiscrub® (Chlorhexidine)
|
Formulary
|
|
|
|
CX Antiseptic Dusting Powder® (Chlorhexidine)
|
Formulary
|
|
|
|
Hibitane Obstetric®
(Chlorhexidine)
|
Formulary
|
Cream
|
|
|
Unisept® (Chlorhexidine Gluconate 0.05%)
|
Formulary
|
Sachets
|
|
|
|
|
| 13.11.03 |
Cationic surfactants and soaps |
|
|
| 13.11.04 |
Iodine and Chlorine |
|
|
Povidone-Iodine (Betadine® or Videne®)
|
Formulary
|
|
|
|
|
|
Triclosan 2% (Aquasept®)
|
Formulary
|
Usage has been replaced by Hibiscrub
|
|
|
| 13.11.06 |
Oxidisers, and dyes |
|
|
Crystacide® (Hydrogen Peroxide 1%)
|
Formulary
|
Cream
|
|
|
Hydrogen Peroxide Solution BP
|
Formulary
|
|
|
|
Potassium Permanganate (Permitabs®)
|
Formulary
|
Solution tablets
|
NHS Patient Safety Alert (2014): Risk of death or serious harm from accidental ingestion of potassium permanganate
|
| 13.11.07 |
Desloughing agents |
|
|
| 13.12 |
Antiperspirants |
|
|
Aluminimum Chloride Hexahydrate 20% in Alcoholic Base (Anhydrol Forte® or Driclor®)
|
Formulary
|
|
|
|
Glycopyrronium bromide
|
Restricted
|
Dermatology only
|
|
|
| 13.13 |
Topical circulatory preparations |
|
|
Heparinoid 0.3% (Hirudoid®)
|
Formulary
|
Cream
|
|
|
| .... |
| Non Formulary Items |
Abrasive Agents (Brasivol®)
|
Non Formulary
|
|
|
|
Adapalene (Differin®)
|
Non Formulary
|
|
|
|
Adapalene with benzoyl peroxide (Epiduo®)
|
Non Formulary
|
|
|
|
Alclometasone Dipopionate (Modrasone®)
|
Non Formulary
|
|
|
|
Alphosyl HC®
|
Non Formulary
|
DISCONTINUED |
|
|
Aquadrate®
|
Non Formulary
|
|
|
|
Aveeno® Bath Oil
|
Non Formulary
|
|
|
|
Azelaic Acid (Finacae®)
|
Non Formulary
|
|
|
|
Azelaic Acid (Skinoren®)
|
Non Formulary
|
|
|
|
Balneum® Bath Oil
|
Non Formulary
|
|
|
|
Balneum® cream
|
Non Formulary
|
|
|
|
Beclometasone Dipropionate 0.025%
|
Non Formulary
|
|
|
|
Benzoic Acid
|
Non Formulary
|
|
|
|
Benzoyl Peroxide (Brevoxyl®)
|
Non Formulary
|
|
|
|
Benzoyl Peroxide (PanOxyl®)
|
Non Formulary
|
|
|
|
Benzoyl Peroxide 5% with Clindamycin 1% (Duac® Once Daily)
|
Non Formulary
|
|
|
|
Benzyl Benzoate Application BP 25%
|
Non Formulary
|
|
|
|
Betadine® Shampoo
|
Non Formulary
|
|
|
|
Betamethasone (as Dipropionate) 0.05% (Diprosone®)
|
Non Formulary
|
|
|
|
Betamethasone Esters (Betesil®)
|
Non Formulary
|
|
|
|
Betamethasone valerate 0.12% (Bettamousse®)
|
Non Formulary
|
|
|
|
Borderline Substances (Delph®)
|
Non Formulary
|
|
|
|
Borderline Substances (SpectraBan®)
|
Non Formulary
|
|
|
|
Carbaryl (Carylderm®)
|
Non Formulary
|
DISCONTINUED |
|
|
Carbo-Dome® (Coal Tar 10%)
|
Non Formulary
|
DISCONTINUED |
|
|
Cetraben®Bath additive
|
Non Formulary
|
|
|
|
Cidofovir in Unguentum M
|
Non Formulary
|
|
|
|
Clinitar®
|
Non Formulary
|
DISCONTINUED |
|
|
Clinitar® Shampoo
|
Non Formulary
|
|
|
|
Clobetasol propionate (Clarelux®)
|
Non Formulary
|
|
|
|
Clobetasol Propionate with Neomycin and Nystatin
|
Non Formulary
|
|
|
|
Cocois®
(Coal Tar 12%)
|
Non Formulary
|
|
|
|
Cocois®
|
Non Formulary
|
|
|
|
Coconut, anise, and ylang ylang spray (Lyclear SprayAway)
|
Non Formulary
|
|
|
|
Collodion Flexible BP
|
Non Formulary
|
|
|
|
Corticosteroids (Actinac®)
|
Non Formulary
|
|
|
|
Covermark®
|
Non Formulary
|
|
|
|
Dermablend®
|
Non Formulary
|
|
|
|
Dermacolor®
|
Non Formulary
|
|
|
|
Dermalo®
|
Non Formulary
|
|
|
|
Dermatonics Heel Balm®
|
Non Formulary
|
|
|
|
Dermax® Shampoo
|
Non Formulary
|
|
|
|
Dermol® 200 shower emollient
|
Non Formulary
|
|
|
|
Dermol® Wash Emulsion
|
Non Formulary
|
|
|
|
Diclofenac 3% Gel (Solaraze®)
|
Non Formulary
|
|
|
|
Diflucortolone Valerate (Nerisone Forte®)
|
Non Formulary
|
|
|
|
Diflucortolone Valerate 0.1% (Nerisone®)
|
Non Formulary
|
|
|
|
Dithranol (Psorin®)
|
Non Formulary
|
|
|
|
Dithranol Ointment BP
|
Non Formulary
|
|
|
|
Doublebase®
|
Non Formulary
|
Bath additive
Shower gel |
|
|
Doxepin (Xepin®)
|
Non Formulary
|
Cream |
|
|
Doxepin Hydrochloride (Xepin®)
|
Non Formulary
|
|
|
|
E45® Bath Additive
|
Non Formulary
|
Bath oil
Emollient wash cream |
|
|
E45® Itch Relief
|
Non Formulary
|
Cream
|
|
|
E45® Lotion
|
Non Formulary
|
Lotion |
|
|
Econazole (Pevaryl®)
|
Non Formulary
|
|
|
|
Eczmol®
|
Non Formulary
|
Cream |
|
|
Efalizumab (Raptiva®)
|
Non Formulary
|
|
|
|
Emollient Bath Additive (Alpha Keri Bath®)
|
Non Formulary
|
|
|
|
Emollient Bath Additive (Diprobath®)
|
Non Formulary
|
|
|
|
Emollient Bath Additive (Imuderm®)
|
Non Formulary
|
|
|
|
Emollient Bath Additive (QV®)
|
Non Formulary
|
|
|
|
Emollient Bath Additive with Anitmicrobials (Dermol®)
|
Non Formulary
|
|
|
|
Emollient Bath Additives (Zerozole®)
|
Non Formulary
|
|
|
|
Emollient preparation (Decubal® Clinic)
|
Non Formulary
|
|
|
|
Emollient preparation (Dermamist®)
|
Non Formulary
|
|
|
|
Emollient preparation (Drapolene®)
|
Non Formulary
|
|
|
|
Emollient preparation (Hewletts®)
|
Non Formulary
|
|
|
|
Emollient preparation (Kamillosan®)
|
Non Formulary
|
|
|
|
Emollient preparation (Keri®)
|
Non Formulary
|
|
|
|
Emollient preparation (Linola® Gamma)
|
Non Formulary
|
|
|
|
Emollient preparation (Neutogena® Dermatological Cream)
|
Non Formulary
|
|
|
|
Emollient preparation (Vaseline Dermacare®)
|
Non Formulary
|
|
|
|
Emollient preparation containing Urea (E45® Itch Releif Cream)
|
Non Formulary
|
|
|
|
Emollient preparation with antimicrobials (Zerolatum® Plus)
|
Non Formulary
|
|
|
|
Emollin®
|
Non Formulary
|
|
|
|
Eucerin® Intensive
|
Non Formulary
|
|
|
|
Exorex®
(Coal tar 5%)
|
Non Formulary
|
|
|
|
Finasteride (Propecia®)
|
Non Formulary
|
 Not NHS |
|
|
Flexitol® Heel Balm
|
Non Formulary
|
|
|
|
Fluocortolone (Ultralanum Plain®)
|
Non Formulary
|
|
|
|
Fluorouracil (Efudix®)
|
Non Formulary
|
|
|
|
Fluticasone Propionate (Cutivate®)
|
Non Formulary
|
|
|
|
Formaldehyde (Veracur®)
|
Non Formulary
|
|
|
|
Full Marks® (Phenothrin)
|
Non Formulary
|
|
|
|
Glutaraldehyde (Glutarol®)
|
Non Formulary
|
|
|
|
Griseofulvin (Grisol AF®)
|
Non Formulary
|
|
|
|
Hydrocortisone (Dioderm®)
(0.1%)
|
Non Formulary
|
|
|
|
Hydrocortisone (Efcortelan®)
|
Non Formulary
|
|
|
|
Hydrocortisone (Hydromol® HC Intensive)
|
Non Formulary
|
|
|
|
Hydrocortisone (Mildison®)
|
Non Formulary
|
|
|
|
Hydrocortisone 0.25% Crotamiton 10% (Eurax-Hydrocortisone®)
|
Non Formulary
|
DISCONTINUED |
|
|
Hydrocortisone 1% with Urea 10% (Alphaderm®)
|
Non Formulary
|
|
|
|
Hydrocortisone 1%, Clioquinol 3% (Vioform-Hydrocortisone®)
|
Non Formulary
|
|
|
|
Hydrocortisone Acetate 1% with Oxytetracycline 3% (Terra-Cortril®)
|
Non Formulary
|
|
|
|
Hydrocortisone Butyrate (Locoid Crelo®)
|
Non Formulary
|
|
|
|
Hydrocortisone Butyrate 0.1% with Chlorquinaldol 3% (Locoid C®)
|
Non Formulary
|
DISCONTINUED |
|
|
Hydrocortisone with antimicrobials (Econacort®)
|
Non Formulary
|
|
|
|
Hydromol® cream
|
Non Formulary
|
Cream |
|
|
Hydromol® Intensive
|
Non Formulary
|
|
|
|
Ichthammol preparations
|
Non Formulary
|
|
|
|
Idoxuridine in Dimethyl Sulfoxide (Herpid®)
|
Non Formulary
|
|
|
|
Imiquimod (Zyclara®)
|
Non Formulary
|
|
|
|
Isotretinoin with antibacterial (Isotrexin®)
|
Non Formulary
|
|
|
|
Keromask®
|
Non Formulary
|
|
|
|
Lanolin emollient spray
|
Non Formulary
|
|
|
|
Medicaid®
|
Non Formulary
|
|
|
|
Meted® Shampoo
|
Non Formulary
|
|
|
|
Micanol® (Dithranol)
|
Non Formulary
|
|
|
|
Minoxidil (Regaine®)
|
Non Formulary
|
Not NHS |
|
|
Morhulin®
|
Non Formulary
|
|
|
|
Neomycin Sulphate 0.5% Cream
|
Non Formulary
|
|
|
|
Nicotinamide (Nicam®)
|
Non Formulary
|
|
|
|
Nutraplus®
|
Non Formulary
|
|
|
|
Oilatum® shower emollient gel
|
Non Formulary
|
|
|
|
Penciclovir (Vectavir®)
|
Non Formulary
|
|
|
|
Pentrax® Shampoo
|
Non Formulary
|
|
|
|
Pinetarsol®
|
Non Formulary
|
|
|
|
Polytar Emollient® (Coal Tar Solution 2.5%, Arachis (peanut) Oil extract of Coal Tar 7.5%, Tar 7.5%, Cade Oil 7.5%, Liqi)
|
Non Formulary
|
|
|
|
Polytar Plus®
|
Non Formulary
|
|
|
|
Potassium hydroxide 5% solution (Molludab®)
|
Non Formulary
|
|
|
|
Potassium Permanganate Solution
|
Non Formulary
|
|
|
|
Povidone-Iodine (Savlon® Dry Antiseptic)
|
Non Formulary
|
DISCONTINUED |
|
|
Prioderm® (Malathion)
|
Non Formulary
|
DISCONTINUED |
|
|
Psoriderm® (Coal tar 40%)
|
Non Formulary
|
Bath Emulsion |
|
|
Psoriderm® Shampoo
|
Non Formulary
|
|
|
|
Quellada M® (Malathion)
|
Non Formulary
|
DISCONTINUED |
|
|
Salicyic Acid in White Soft Paraffin
|
Non Formulary
|
|
|
|
Salicylic Acid (Acnisal®)
|
Non Formulary
|
|
|
|
Salicylic Acid (Cuplex®)
|
Non Formulary
|
|
|
|
Salicylic Acid (Occlusal®)
|
Non Formulary
|
|
|
|
Salicylic Acid (Phytex®)
|
Non Formulary
|
|
|
|
Salicylic Acid (Salatac®)
|
Non Formulary
|
|
|
|
Salicylic Acid (Verrugon®)
|
Non Formulary
|
|
|
|
Salicylic Acid 3% w/w, Sulphur 3% w/w in Aqueous Cream
|
Non Formulary
|
|
|
|
Salicylic Acid 3% w/w, Sulphur 3% w/w in Aqueous Cream
|
Non Formulary
|
|
|
|
Salicylic Acid in White Soft Paraffin
|
Non Formulary
|
|
|
|
Salicylic Acid in White Soft Paraffin
|
Non Formulary
|
|
|
|
Salicylic Acid with podophyllum (Posalfflin®)
|
Non Formulary
|
|
|
|
Silver Nitrate
|
Non Formulary
|
|
|
|
Sorbaderm®
|
Non Formulary
|
Obtained through SUPPLIES |
|
|
Sulconazole Nitrate (Exelderm®)
|
Non Formulary
|
|
|
|
Sunscreen (Roc®)
|
Non Formulary
|
|
|
|
Tazarotene 0.05% (Zorac®)
|
Non Formulary
|
|
|
|
Tioconazole (Trosyl®)
|
Non Formulary
|
|
|
|
Tretinoin (Retin-A®)
|
Non Formulary
|
DISCONTINUED |
|
|
Tretinoin with antibacterial (Aknemycin® Plus)
|
Non Formulary
|
|
|
|
Tri-Adcortyl®
|
Non Formulary
|
|
|
|
Triclosan (Manusept®)
|
Non Formulary
|
|
|
|
Triclosan 1% (Skinsan®)
|
Non Formulary
|
|
|
|
Triclosan 2% (Ster-Zac Bath Concentrate®)
|
Non Formulary
|
|
|
|
Ultrabase®
|
Non Formulary
|
|
|
|
Undecenoates (Monphytol®)
|
Non Formulary
|
|
|
|
Undecenoates (Mycota®)
|
Non Formulary
|
|
|
|
Vasogen®
|
Non Formulary
|
|
|
|
Veil®
|
Non Formulary
|
|
|
|
ZeroAQS®
|
Non Formulary
|
Cream |
|
|
Zerocream®
|
Non Formulary
|
|
|
|
Zeroderm®
|
Non Formulary
|
|
|
|
Zeroguent®
|
Non Formulary
|
|
|
|
Zerolatum® Bath Additive (Zerolatum®)
|
Non Formulary
|
|
|
|
Zeroneum® Bath Oil
|
Non Formulary
|
|
|
|
Zinc and Caster Oil Ointment BP
|
Non Formulary
|
|
|
|
Zinc Cream BP
|
Non Formulary
|
|
|
|
Zinc Ointment BP
|
Non Formulary
|
|
|
|
| |
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
Drugs designated amber are suitable for shared care arrangements under a shared care protocol.
Prescribing may be transferred from secondary to primary care once the patient is stabilised and agreed shared care arrangements have been established. Alternatively primary care may initiate under the supervision of secondary care if this option is given in the shared care document. It is recommended that shared care arrangements should be drawn up following local discussion and agreement by prescribing parties.
|
|
These products have been reviewed by the GM Joint Formulary Group and have been deemed not suitable for prescribing for adults in primary or secondary care within Greater Manchester. These decisions have been made on the basis of safety, efficacy and cost-effectiveness of the products. |
|
Not used
|
|
Drugs designated green1 are suitable for initiation and ongoing prescribing within primary care. |
|
Drugs designated green2 can be initiated by primary care following written or verbal advice from a specialist and then be subsequently safely prescribed in primary care with little or no monitoring required. |
|
Drugs designated green3 are suitable for on-going prescribing within primary care after specialist initiation and an initial review (unless specified) in secondary care. Little or no monitoring is required. |
|
Not suitable for routine prescribing but may be suitable for a defined patient population. Whilst prescribers should think very carefully before prescribing or recommending any of the products on the grey list, there may be exceptional instances when the use of one of these products is necessary for a particular patient. |
|
Drugs designated red are considered to be specialist medicines and prescribing responsibility for these medicines should normally remain with the consultant or specialist clinician. These drugs should not be initiated or prescribed in primary care. It is recommended that the supply of these specialist medicines should be organised via the hospital pharmacy, this may include arranging for supply via a home care company.
|
|
|
|
